NASDAQ:AMEH - Apollo Medical Stock Price, Forecast & News

Apollo Medical's stock was trading at $14.07 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AMEH stock has decreased by 7.0% and is now trading at $13.09. View which stocks have been mosted impacted by Coronavirus.

Apollo Medical is scheduled to release its next quarterly earnings announcement on Monday, May 11th 2020. View our earnings forecast for Apollo Medical.

Apollo Medical Holdings Inc (NASDAQ:AMEH) issued its quarterly earnings data on Thursday, March, 12th. The company reported $0.18 EPS for the quarter, missing the consensus estimate of $0.20 by $0.02. The business had revenue of $178.75 million for the quarter. Apollo Medical had a return on equity of 8.34% and a net margin of 2.52%. View Apollo Medical's earnings history.

Apollo Medical issued an update on its FY 2020 Pre-Market earnings guidance on Thursday, March, 12th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $665-675 million, compared to the consensus revenue estimate of $664 million.

News headlines about AMEH stock have trended somewhat negative recently, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Apollo Medical earned a news sentiment score of -1.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next few days. View the latest news aboutApollo Medical.

Apollo Medical saw a decline in short interest during the month of February. As of February 28th, there was short interest totaling 630,100 shares, a decline of 5.7% from the February 13th total of 668,100 shares. Based on an average daily trading volume, of 90,100 shares, the days-to-cover ratio is currently 7.0 days. Currently, 7.4% of the company's shares are short sold. View Apollo Medical's Current Options Chain.

Some companies that are related to Apollo Medical include NIC (EGOV), ICF International (ICFI), Huron Consulting Group (HURN), RMR Group (RMR), The Hackett Group (HCKT), Diamond Eagle Acquisition (ATCX), Blackrock Capital Investment (BKCC), Information Services Group (III), Avalon Globocare (AVCO), ATIF (ATIF), TSS (TSSI), Pharma Bio Serv (PBSV), Wilhelmina International (WHLM), China Internet Nationwide Fncl Srvcs (CIFS) and Lightbridge (LTBR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include Paypal (PYPL), Gilead Sciences (GILD), NVIDIA (NVDA), Trade Desk (TTD), Bristol-Myers Squibb (BMY), SEA (SE), Okta (OKTA), Snap (SNAP), Advanced Micro Devices (AMD) and Momo (MOMO).

Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH."

Apollo Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include Geode Capital Management LLC (0.80%), State Street Corp (0.66%), THB Asset Management (0.39%), Charles Schwab Investment Management Inc. (0.31%), Bank of New York Mellon Corp (0.18%) and Virginia Retirement Systems ET AL (0.17%). Company insiders that own Apollo Medical stock include Adrian Vazquez, Albert Waichow Young, Eric Chin, John Chiang, Kenneth T Sim, Mark Fawcett, Michael F Eng, Physicians Of Californi Allied, Thomas S Lam and Warren Hosseinion. View institutional ownership trends for Apollo Medical.

AMEH stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, Goldman Sachs Group Inc., Nuveen Asset Management LLC, Geode Capital Management LLC, Charles Schwab Investment Management Inc., Bank of New York Mellon Corp, New York State Common Retirement Fund, and Rhumbline Advisers. View insider buying and selling activity for Apollo Medical.

AMEH stock was acquired by a variety of institutional investors in the last quarter, including Virginia Retirement Systems ET AL, Zebra Capital Management LLC, Martingale Asset Management L P, Cubist Systematic Strategies LLC, UBS Asset Management Americas Inc., Bessemer Group Inc., THB Asset Management, and Alliancebernstein L.P.. Company insiders that have bought Apollo Medical stock in the last two years include Albert Waichow Young, Eric Chin, John Chiang, Kenneth T Sim, Mark Fawcett, Michael F Eng, Physicians Of Californi Allied, and Thomas S Lam. View insider buying and selling activity for Apollo Medical.

Shares of AMEH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of AMEH stock can currently be purchased for approximately $13.09.

Apollo Medical has a market capitalization of $456.71 million and generates $560.62 million in revenue each year. The company earns $14.12 million in net income (profit) each year or $0.43 on an earnings per share basis. Apollo Medical employs 475 workers across the globe. View additional information about Apollo Medical.

The official website for Apollo Medical is http://www.apollomed.net/.

Apollo Medical's mailing address is 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801. The company can be reached via phone at 626-282-0288 or via email at [email protected]